Suspected VITT blood clotting case after Johnson & Johnson COVID-19 vaccination

University of Utah Health announces a suspected case of vaccine-induced thrombotic thrombocytopenia (VITT), also called thrombosis and thrombocytopenia syndrome (TTS), after receiving the Johnson & Johnson COVID-19 vaccine. Confirmation of the diagnosis by the U.S. Centers for Disease Control and Prevention (CDC) is pending.

Organ transplant recipients vulnerable to COVID-19 even after vaccination

In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2—the virus that causes COVID 19—confers some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical …

Piecing together the preterm infant microbiome

The human microbiome—the collection of microbes living in the gut—is now recognized as an important contributor to health and disease. The environment, the host, and microbe-microbe interactions are all likely to shape the microbiome’s dynamics, but the unique roles of each are not well understood. Now, a Boston Children’s Hospital infectious disease researcher reveals how …